Upregulation of β-catenin expression in down syndrome model Ts65Dn mouse brain

Neuroscience

Volumn 161, Issue 2, 2009, Pages 451-458

  Ramakrishna, N ^a   Meeker, H C ^a   Li, S ^a   Brown, W T ^a   Rao, R ^a   El Idrissi, A ^b  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

catenin; chromosome 21; Down syndrome; endothelial cell; trisomy; Ts65Dn mouse

Indexed keywords

ALPHA CATENIN; BETA ACTIN; BETA CATENIN; BETA TUBULIN; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD VESSEL; BRAIN TISSUE; CELL ADHESION; CELL FUNCTION; CHROMOSOME 16; CHROMOSOME 9; CONTROLLED STUDY; DOWN SYNDROME; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RNA EXTRACTION;

ALPHA CATENIN; ANIMALS; BETA CATENIN; BLOOD VESSELS; BRAIN; CADHERINS; CEREBRAL CORTEX; CHROMOSOMES, MAMMALIAN; DOWN SYNDROME; DOWN-REGULATION; GLYCOGEN SYNTHASE KINASE 3; IMMUNOHISTOCHEMISTRY; MICE; MICE, MUTANT STRAINS; PRESENILIN-1; RNA, MESSENGER; UP-REGULATION;

EID: 67349127561     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.03.049     Document Type: Article

References (32)

1. Antonarakis S.E., Lyle R., Dermitzakis E.T., Reymond A., and Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 5 (2004) 725-738
2. Barolo S. Transgenic Wnt/TCF pathway reports: all you need is Lef?. Oncogene 25 (2006) 7505-7511
3. Busciglio J., and Yankner B.A. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378 (1995) 776-779
4. Capelli-Bigazzi M., Santoro G., Battaglia C., Palldino M.T., Carrozza M., Russo M.G., Pacielo G., and Calabro R. Endothelial cell function in patients with Down syndrome. Am J Cardiol 94 (2004) 392-395
5. Chen Y.Z. APP induces neuronal apoptosis through APP-BP1-mediated downregulation of beta-catenin. Apoptosis 9 (2004) 415-422
6. Davisson M.T., Schmidt C., Reeves R.H., Irving N.G., Akeson E.C., Harris B.S., and Bronson R.T. Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res 384 (1993) 117-133
7. de Borchgrave V., Saussu F., Depre A., and de Barsy T. Moyamoya disease and Down syndrome: case report and review of the literature. Acta Neurol Belg 102 (2002) 63-66
8. Epstein C.J., Korenberg J.R., Anneren G., Antonarakis S.E., Ayme S., Courchesne E., Epstein L.B., Fowler A., Groner Y., Huret J.L., et al. Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet 49 (1991) 207-235
9. Gatenby P., Tuck R., Andrews C., and O'Nei R. Antiphospholipid antibodies and stroke in Down syndrome. Lupus 12 (2003) 58-62
10. Gordon M.D., and Nusse R. Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281 (2006) 22429-22433
11. Herington J.L., Bi J., Martin J.D., and Bany B.M. Beta-catenin (CTNNB1) in the mouse uterus during decidualization and the potential role of two pathways in regulating its degradation. J Histochem Cytochem 55 (2007) 963-974
12. Kaga S., Zhan L., Altaf E., and Maulik N. Glycogen synthase kinase-3 beta/beta-catenin promotes angiogenic and antiapoptotic signalling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol 40 (2006) 138-147
13. Kahlem P., Sultan M., Herwig R., Steinfath M., Balzereit D., Eppens B., Saran N.G., Pletcher M.T., South S.T., Stetten G., Lehrach H., Reeves R.H., and Yaspo M.L. Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of Down syndrome. Genome Res 14 (2004) 1258-1267
14. Kang D.E., Soriano S., Frosch M.P., Collins T., Naruse S., Sisodia S.S., Leibowitz G., Levine F., and Koo E.H. Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J Neurosci 19 (1999) 4229-4237
15. Krizbai I.A., Bauer H., Bresgen N., Eckl P.M., Farkas A., Szatmari E., Traweger A., Wejksza K., and Bauer H.C. Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell Mol Neurobiol 25 (2005) 129-139
16. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., and Kinzler K.W. Activation of beta-catenin-TCF signalling in colon cancer by mutations in beta-catenin or APC. Science 275 (1997) 1787-1790
17. Murayama M., Tanaka S., Palacino J., Murayama O., Honda T., Sun X., Yasutake K., Nihonmatsu N., Wolozin B., and Takashima A. Direct association of presenilin-1 with beta-catenin. FEBS Lett 433 (1998) 73-77
18. Novak A., and Dedhar S. Signalling through beta-catenin and Lef/Tcf. Cell Mol Life Sci 56 5-6 (1999) 523-537
19. Palminiello S., Kida E., Kaur K., Walus M., Wisniewski K.E., Wierzba-Bobrowicz T., Rabe A., Albertini G., and Golabek A.A. Increased levels of carbonic anhydrase II in the developing Down syndrome brain. Brain Res 1190 (2008) 193-205
20. Pastorekova S., Parkkila S., Pastorek J., and Supuran C.T. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects. J Enzyme Inhib Med Chem 19 (2004) 199-229
21. Peifer M., and Polakis P. Wnt signalling in oncogenesis and embryogenesis: a look outside the nucleus. Science 287 (2000) 1606-1609
22. Perl A.K., Wilgenbus P., Dahl U., Semb H., and Christofori G. A casual role for E-cadherin in the transition from adenoma to carcinoma. Nature 392 (1998) 190-193
23. Pollonini G., Gao V., Rabe A., Palminiello S., Albertini G., and Alberini C.M. Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn. Neuroscience 156 (2008) 99-106
24. Puri B.K., Ho K.W., and Singh I. Age of seizure onset in adults with Down syndrome. Int J Clin Pract 55 (2001) 442-444
25. Ramakrishna N., Meeker C., Li S., Jenkins E.C., Currie J.R., Flory M., Lee B., Liu M.S., and Miller D.L. Polymerase chain reaction method to identify Down syndrome model segmentally trisomic mice. Anal Biochem 340 (2005) 213-219
26. Ramakrishna N., Smedman M., Ramakrishna V., and Gillam B. Upregulation of actin gene expression in cells expressing exogenous beta-amyloid precursor protein. Biochem Biophys Res Commun 231 (1997) 615-618
27. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., Schmidt C., Bronson R.T., and Davisson M.T. A mouse model for Down syndrome exhibits learning and behavioural deficits. Nat Genet 11 (1995) 177-184
28. Salinas P.C., and Price S.R. Cadherins and catenins in synapse development. Curr Opin Neurobiol 15 (2005) 73-80
29. Saran N.G., Pletcher M.T., Natale J.E., Cheng Y., and Reeves R.H. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet 12 (2003) 2013-2019
30. Vestweber D., and Kemler R. Identification of a putative cell adhesion domain of uvomorulin. EMBO J 4 (1985) 3393-3398
31. Vorbrodt A.W., Li S., Brown W.T., and Ramakrishna N. Increased expression of beta-catenin in brain microvessels of a segmentally trisomic (Ts65Dn) mouse model of Down syndrome. Brain Biol Cell Press (2009) in press
32. Yap A.S., Brieher W.M., and Gumbiner B.M. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 13 (1997) 119-146